Fifteen Texas Hospitals Chosen to Receive Remdesivir

Fifteen Texas hospitals are slated to receive shipments of remdesivir, as announced today by the Texas Department of State Health Services (DSHS). The medication will be used to treat patients infected with coronavirus disease 2019 (COVID-19).

According to the DSHS press release, the antiviral medication “has shown promise in early trials in speeding up the recovery time among hospitalized COVID-19 patients.”

Preliminary results from a clinical trial showed the average recovery time among patients who received remdesivir was 11 days versus 15 days with a placebo. Those preliminary results did not show significant survival benefit.

The medication is being provided by the federal government from a supply originally donated by Gilead, the manufacture of the drug.

Fifteen Texas hospitals in 14 communities will receive at least 1 case of the drug. Each case contains 40 vials of the drug. The drug must be prescribed in accordance with the Food and Drug Administration’s Emergency Use Authorization for remdesivir.

The 15 named hospitals are:

Dr. Julie Reagan

Julie Reagan, PhD, JD, MPH, is a public health expert and researcher with a doctorate degree in public health. She is an academic professor who teaches public health, healthcare administration, and public health law courses. Dr. Reagan is also a licensed attorney with over 20 years of experience as a state government attorney, primarily at public health agencies. She was the 2018 recipient of the American Public Health Association, Law Section, Jennifer Robbins Award for the Practice of Public Health Law.

Recent Posts